309 related articles for article (PubMed ID: 24060151)
1. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
3. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
4. Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis.
Brunetti B; Asproni P; Beha G; Muscatello LV; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2013 Feb; 148(2-3):206-13. PubMed ID: 22819018
[TBL] [Abstract][Full Text] [Related]
5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
6. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
7. Hormonal background of canine and feline mammary tumours.
Rutteman GR; Misdorp W
J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
[TBL] [Abstract][Full Text] [Related]
8. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
10. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
11. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
13. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
Millanta F; Asproni P; Canale A; Citi S; Poli A
Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
[TBL] [Abstract][Full Text] [Related]
14. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
[TBL] [Abstract][Full Text] [Related]
15. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours.
Muscatello LV; Sarli G; Beha G; Asproni P; Millanta F; Poli A; De Tolla LJ; Benazzi C; Brunetti B
J Comp Pathol; 2015; 152(2-3):153-60. PubMed ID: 25670670
[TBL] [Abstract][Full Text] [Related]
16. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
17. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
Kim NH; Lim HY; Im KS; Kim JH; Sur JH
J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
[TBL] [Abstract][Full Text] [Related]
18. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
[TBL] [Abstract][Full Text] [Related]
19. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
Seixas F; Pires MA; Lopes CA
Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T
BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]